Sexually Transmitted Diseases (STD) Treatment Market - Global Outlook and Forecast 2023-2028

Report ID: 1370511 | Published Date: Jan 2025 | No. of Page: 66 | Base Year: 2024 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Sexually Transmitted Diseases (STD) Treatment Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Sexually Transmitted Diseases (STD) Treatment Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Sexually Transmitted Diseases (STD) Treatment Overall Market Size
    2.1 Global Sexually Transmitted Diseases (STD) Treatment Market Size: 2021 VS 2028
    2.2 Global Sexually Transmitted Diseases (STD) Treatment Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Sexually Transmitted Diseases (STD) Treatment Players in Global Market
    3.2 Top Global Sexually Transmitted Diseases (STD) Treatment Companies Ranked by Revenue
    3.3 Global Sexually Transmitted Diseases (STD) Treatment Revenue by Companies
    3.4 Top 3 and Top 5 Sexually Transmitted Diseases (STD) Treatment Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Sexually Transmitted Diseases (STD) Treatment Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Sexually Transmitted Diseases (STD) Treatment Players in Global Market
        3.6.1 List of Global Tier 1 Sexually Transmitted Diseases (STD) Treatment Companies
        3.6.2 List of Global Tier 2 and Tier 3 Sexually Transmitted Diseases (STD) Treatment Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Sexually Transmitted Diseases (STD) Treatment Market Size Markets, 2021 & 2028
        4.1.2 Viral Infections
        4.1.3 Bacterial Infections
        4.1.4 Others
    4.2 By Type - Global Sexually Transmitted Diseases (STD) Treatment Revenue & Forecasts
        4.2.1 By Type - Global Sexually Transmitted Diseases (STD) Treatment Revenue, 2017-2022
        4.2.2 By Type - Global Sexually Transmitted Diseases (STD) Treatment Revenue, 2023-2028
        4.2.3 By Type - Global Sexually Transmitted Diseases (STD) Treatment Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Sexually Transmitted Diseases (STD) Treatment Market Size, 2021 & 2028
        5.1.2 Hospitals
        5.1.3 Clinics
        5.1.4 Others
    5.2 By Application - Global Sexually Transmitted Diseases (STD) Treatment Revenue & Forecasts
        5.2.1 By Application - Global Sexually Transmitted Diseases (STD) Treatment Revenue, 2017-2022
        5.2.2 By Application - Global Sexually Transmitted Diseases (STD) Treatment Revenue, 2023-2028
        5.2.3 By Application - Global Sexually Transmitted Diseases (STD) Treatment Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Sexually Transmitted Diseases (STD) Treatment Market Size, 2021 & 2028
    6.2 By Region - Global Sexually Transmitted Diseases (STD) Treatment Revenue & Forecasts
        6.2.1 By Region - Global Sexually Transmitted Diseases (STD) Treatment Revenue, 2017-2022
        6.2.2 By Region - Global Sexually Transmitted Diseases (STD) Treatment Revenue, 2023-2028
        6.2.3 By Region - Global Sexually Transmitted Diseases (STD) Treatment Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Sexually Transmitted Diseases (STD) Treatment Revenue, 2017-2028
        6.3.2 US Sexually Transmitted Diseases (STD) Treatment Market Size, 2017-2028
        6.3.3 Canada Sexually Transmitted Diseases (STD) Treatment Market Size, 2017-2028
        6.3.4 Mexico Sexually Transmitted Diseases (STD) Treatment Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Sexually Transmitted Diseases (STD) Treatment Revenue, 2017-2028
        6.4.2 Germany Sexually Transmitted Diseases (STD) Treatment Market Size, 2017-2028
        6.4.3 France Sexually Transmitted Diseases (STD) Treatment Market Size, 2017-2028
        6.4.4 U.K. Sexually Transmitted Diseases (STD) Treatment Market Size, 2017-2028
        6.4.5 Italy Sexually Transmitted Diseases (STD) Treatment Market Size, 2017-2028
        6.4.6 Russia Sexually Transmitted Diseases (STD) Treatment Market Size, 2017-2028
        6.4.7 Nordic Countries Sexually Transmitted Diseases (STD) Treatment Market Size, 2017-2028
        6.4.8 Benelux Sexually Transmitted Diseases (STD) Treatment Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Sexually Transmitted Diseases (STD) Treatment Revenue, 2017-2028
        6.5.2 China Sexually Transmitted Diseases (STD) Treatment Market Size, 2017-2028
        6.5.3 Japan Sexually Transmitted Diseases (STD) Treatment Market Size, 2017-2028
        6.5.4 South Korea Sexually Transmitted Diseases (STD) Treatment Market Size, 2017-2028
        6.5.5 Southeast Asia Sexually Transmitted Diseases (STD) Treatment Market Size, 2017-2028
        6.5.6 India Sexually Transmitted Diseases (STD) Treatment Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Sexually Transmitted Diseases (STD) Treatment Revenue, 2017-2028
        6.6.2 Brazil Sexually Transmitted Diseases (STD) Treatment Market Size, 2017-2028
        6.6.3 Argentina Sexually Transmitted Diseases (STD) Treatment Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Sexually Transmitted Diseases (STD) Treatment Revenue, 2017-2028
        6.7.2 Turkey Sexually Transmitted Diseases (STD) Treatment Market Size, 2017-2028
        6.7.3 Israel Sexually Transmitted Diseases (STD) Treatment Market Size, 2017-2028
        6.7.4 Saudi Arabia Sexually Transmitted Diseases (STD) Treatment Market Size, 2017-2028
        6.7.5 UAE Sexually Transmitted Diseases (STD) Treatment Market Size, 2017-2028
7 Players Profiles
    7.1 Pfizer
        7.1.1 Pfizer Corporate Summary
        7.1.2 Pfizer Business Overview
        7.1.3 Pfizer Sexually Transmitted Diseases (STD) Treatment Major Product Offerings
        7.1.4 Pfizer Sexually Transmitted Diseases (STD) Treatment Revenue in Global Market (2017-2022)
        7.1.5 Pfizer Key News
    7.2 Roche
        7.2.1 Roche Corporate Summary
        7.2.2 Roche Business Overview
        7.2.3 Roche Sexually Transmitted Diseases (STD) Treatment Major Product Offerings
        7.2.4 Roche Sexually Transmitted Diseases (STD) Treatment Revenue in Global Market (2017-2022)
        7.2.5 Roche Key News
    7.3 Gilead Sciences
        7.3.1 Gilead Sciences Corporate Summary
        7.3.2 Gilead Sciences Business Overview
        7.3.3 Gilead Sciences Sexually Transmitted Diseases (STD) Treatment Major Product Offerings
        7.3.4 Gilead Sciences Sexually Transmitted Diseases (STD) Treatment Revenue in Global Market (2017-2022)
        7.3.5 Gilead Sciences Key News
    7.4 GlaxoSmithKline
        7.4.1 GlaxoSmithKline Corporate Summary
        7.4.2 GlaxoSmithKline Business Overview
        7.4.3 GlaxoSmithKline Sexually Transmitted Diseases (STD) Treatment Major Product Offerings
        7.4.4 GlaxoSmithKline Sexually Transmitted Diseases (STD) Treatment Revenue in Global Market (2017-2022)
        7.4.5 GlaxoSmithKline Key News
    7.5 Johnson & Johnson
        7.5.1 Johnson & Johnson Corporate Summary
        7.5.2 Johnson & Johnson Business Overview
        7.5.3 Johnson & Johnson Sexually Transmitted Diseases (STD) Treatment Major Product Offerings
        7.5.4 Johnson & Johnson Sexually Transmitted Diseases (STD) Treatment Revenue in Global Market (2017-2022)
        7.5.5 Johnson & Johnson Key News
    7.6 Merck
        7.6.1 Merck Corporate Summary
        7.6.2 Merck Business Overview
        7.6.3 Merck Sexually Transmitted Diseases (STD) Treatment Major Product Offerings
        7.6.4 Merck Sexually Transmitted Diseases (STD) Treatment Revenue in Global Market (2017-2022)
        7.6.5 Merck Key News
    7.7 AbbVie
        7.7.1 AbbVie Corporate Summary
        7.7.2 AbbVie Business Overview
        7.7.3 AbbVie Sexually Transmitted Diseases (STD) Treatment Major Product Offerings
        7.7.4 AbbVie Sexually Transmitted Diseases (STD) Treatment Revenue in Global Market (2017-2022)
        7.7.5 AbbVie Key News
    7.8 Bayer
        7.8.1 Bayer Corporate Summary
        7.8.2 Bayer Business Overview
        7.8.3 Bayer Sexually Transmitted Diseases (STD) Treatment Major Product Offerings
        7.8.4 Bayer Sexually Transmitted Diseases (STD) Treatment Revenue in Global Market (2017-2022)
        7.8.5 Bayer Key News
    7.9 Bristol-Myers Squibb
        7.9.1 Bristol-Myers Squibb Corporate Summary
        7.9.2 Bristol-Myers Squibb Business Overview
        7.9.3 Bristol-Myers Squibb Sexually Transmitted Diseases (STD) Treatment Major Product Offerings
        7.9.4 Bristol-Myers Squibb Sexually Transmitted Diseases (STD) Treatment Revenue in Global Market (2017-2022)
        7.9.5 Bristol-Myers Squibb Key News
    7.10 Eli Lilly
        7.10.1 Eli Lilly Corporate Summary
        7.10.2 Eli Lilly Business Overview
        7.10.3 Eli Lilly Sexually Transmitted Diseases (STD) Treatment Major Product Offerings
        7.10.4 Eli Lilly Sexually Transmitted Diseases (STD) Treatment Revenue in Global Market (2017-2022)
        7.10.5 Eli Lilly Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Sexually Transmitted Diseases (STD) Treatment Market Opportunities & Trends in Global Market
    Table 2. Sexually Transmitted Diseases (STD) Treatment Market Drivers in Global Market
    Table 3. Sexually Transmitted Diseases (STD) Treatment Market Restraints in Global Market
    Table 4. Key Players of Sexually Transmitted Diseases (STD) Treatment in Global Market
    Table 5. Top Sexually Transmitted Diseases (STD) Treatment Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Sexually Transmitted Diseases (STD) Treatment Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Sexually Transmitted Diseases (STD) Treatment Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Sexually Transmitted Diseases (STD) Treatment Product Type
    Table 9. List of Global Tier 1 Sexually Transmitted Diseases (STD) Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Sexually Transmitted Diseases (STD) Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Sexually Transmitted Diseases (STD) Treatment Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Sexually Transmitted Diseases (STD) Treatment Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Sexually Transmitted Diseases (STD) Treatment Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Sexually Transmitted Diseases (STD) Treatment Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Sexually Transmitted Diseases (STD) Treatment Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Sexually Transmitted Diseases (STD) Treatment Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Sexually Transmitted Diseases (STD) Treatment Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Sexually Transmitted Diseases (STD) Treatment Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Sexually Transmitted Diseases (STD) Treatment Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Sexually Transmitted Diseases (STD) Treatment Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Sexually Transmitted Diseases (STD) Treatment Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Sexually Transmitted Diseases (STD) Treatment Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Sexually Transmitted Diseases (STD) Treatment Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Sexually Transmitted Diseases (STD) Treatment Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Sexually Transmitted Diseases (STD) Treatment Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Sexually Transmitted Diseases (STD) Treatment Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Sexually Transmitted Diseases (STD) Treatment Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Sexually Transmitted Diseases (STD) Treatment Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Sexually Transmitted Diseases (STD) Treatment Revenue, (US$, Mn), 2023-2028
    Table 30. Pfizer Corporate Summary
    Table 31. Pfizer Sexually Transmitted Diseases (STD) Treatment Product Offerings
    Table 32. Pfizer Sexually Transmitted Diseases (STD) Treatment Revenue (US$, Mn), (2017-2022)
    Table 33. Roche Corporate Summary
    Table 34. Roche Sexually Transmitted Diseases (STD) Treatment Product Offerings
    Table 35. Roche Sexually Transmitted Diseases (STD) Treatment Revenue (US$, Mn), (2017-2022)
    Table 36. Gilead Sciences Corporate Summary
    Table 37. Gilead Sciences Sexually Transmitted Diseases (STD) Treatment Product Offerings
    Table 38. Gilead Sciences Sexually Transmitted Diseases (STD) Treatment Revenue (US$, Mn), (2017-2022)
    Table 39. GlaxoSmithKline Corporate Summary
    Table 40. GlaxoSmithKline Sexually Transmitted Diseases (STD) Treatment Product Offerings
    Table 41. GlaxoSmithKline Sexually Transmitted Diseases (STD) Treatment Revenue (US$, Mn), (2017-2022)
    Table 42. Johnson & Johnson Corporate Summary
    Table 43. Johnson & Johnson Sexually Transmitted Diseases (STD) Treatment Product Offerings
    Table 44. Johnson & Johnson Sexually Transmitted Diseases (STD) Treatment Revenue (US$, Mn), (2017-2022)
    Table 45. Merck Corporate Summary
    Table 46. Merck Sexually Transmitted Diseases (STD) Treatment Product Offerings
    Table 47. Merck Sexually Transmitted Diseases (STD) Treatment Revenue (US$, Mn), (2017-2022)
    Table 48. AbbVie Corporate Summary
    Table 49. AbbVie Sexually Transmitted Diseases (STD) Treatment Product Offerings
    Table 50. AbbVie Sexually Transmitted Diseases (STD) Treatment Revenue (US$, Mn), (2017-2022)
    Table 51. Bayer Corporate Summary
    Table 52. Bayer Sexually Transmitted Diseases (STD) Treatment Product Offerings
    Table 53. Bayer Sexually Transmitted Diseases (STD) Treatment Revenue (US$, Mn), (2017-2022)
    Table 54. Bristol-Myers Squibb Corporate Summary
    Table 55. Bristol-Myers Squibb Sexually Transmitted Diseases (STD) Treatment Product Offerings
    Table 56. Bristol-Myers Squibb Sexually Transmitted Diseases (STD) Treatment Revenue (US$, Mn), (2017-2022)
    Table 57. Eli Lilly Corporate Summary
    Table 58. Eli Lilly Sexually Transmitted Diseases (STD) Treatment Product Offerings
    Table 59. Eli Lilly Sexually Transmitted Diseases (STD) Treatment Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Sexually Transmitted Diseases (STD) Treatment Segment by Type in 2021
    Figure 2. Sexually Transmitted Diseases (STD) Treatment Segment by Application in 2021
    Figure 3. Global Sexually Transmitted Diseases (STD) Treatment Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Sexually Transmitted Diseases (STD) Treatment Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Sexually Transmitted Diseases (STD) Treatment Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Sexually Transmitted Diseases (STD) Treatment Revenue in 2021
    Figure 8. By Type - Global Sexually Transmitted Diseases (STD) Treatment Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Sexually Transmitted Diseases (STD) Treatment Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Sexually Transmitted Diseases (STD) Treatment Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Sexually Transmitted Diseases (STD) Treatment Revenue Market Share, 2017-2028
    Figure 12. US Sexually Transmitted Diseases (STD) Treatment Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Sexually Transmitted Diseases (STD) Treatment Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Sexually Transmitted Diseases (STD) Treatment Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Sexually Transmitted Diseases (STD) Treatment Revenue Market Share, 2017-2028
    Figure 16. Germany Sexually Transmitted Diseases (STD) Treatment Revenue, (US$, Mn), 2017-2028
    Figure 17. France Sexually Transmitted Diseases (STD) Treatment Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Sexually Transmitted Diseases (STD) Treatment Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Sexually Transmitted Diseases (STD) Treatment Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Sexually Transmitted Diseases (STD) Treatment Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Sexually Transmitted Diseases (STD) Treatment Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Sexually Transmitted Diseases (STD) Treatment Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Sexually Transmitted Diseases (STD) Treatment Revenue Market Share, 2017-2028
    Figure 24. China Sexually Transmitted Diseases (STD) Treatment Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Sexually Transmitted Diseases (STD) Treatment Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Sexually Transmitted Diseases (STD) Treatment Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Sexually Transmitted Diseases (STD) Treatment Revenue, (US$, Mn), 2017-2028
    Figure 28. India Sexually Transmitted Diseases (STD) Treatment Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Sexually Transmitted Diseases (STD) Treatment Revenue Market Share, 2017-2028
    Figure 30. Brazil Sexually Transmitted Diseases (STD) Treatment Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Sexually Transmitted Diseases (STD) Treatment Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Sexually Transmitted Diseases (STD) Treatment Revenue Market Share, 2017-2028
    Figure 33. Turkey Sexually Transmitted Diseases (STD) Treatment Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Sexually Transmitted Diseases (STD) Treatment Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Sexually Transmitted Diseases (STD) Treatment Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Sexually Transmitted Diseases (STD) Treatment Revenue, (US$, Mn), 2017-2028
    Figure 37. Pfizer Sexually Transmitted Diseases (STD) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Roche Sexually Transmitted Diseases (STD) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Gilead Sciences Sexually Transmitted Diseases (STD) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. GlaxoSmithKline Sexually Transmitted Diseases (STD) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Johnson & Johnson Sexually Transmitted Diseases (STD) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Merck Sexually Transmitted Diseases (STD) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. AbbVie Sexually Transmitted Diseases (STD) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Bayer Sexually Transmitted Diseases (STD) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Bristol-Myers Squibb Sexually Transmitted Diseases (STD) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Eli Lilly Sexually Transmitted Diseases (STD) Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
66
Frequently Asked Questions
Sexually Transmitted Diseases Treatment Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Sexually Transmitted Diseases Treatment Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Sexually Transmitted Diseases Treatment Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports